加载中
NASDAQHealthcareMedical - Specialties
最新数据
US$8.60
−US$0.03 · -0.35%
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.
前收盘价
US$8.60
−US$0.03 · -0.35%
盘后
US$8.60
US$0.00 · 0.00%
10月12日 16:10 ET
盘中时间采用ET。市场数据可能有所延迟。
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.
日内区间
当前US$8.60
52周区间
当前US$8.60
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
持有
估值
47
合理估值
情绪
56
多空交织
风险
54
风险偏高
动量
36
动能减弱
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.
日内区间
当前US$8.60
52周区间
当前US$8.60
| 项目（USD） | 2025财年 |
|---|---|
| 营收 | 3204.1万 USD |
| 销货成本 | 606.6万 USD |
| 毛利 | 2597.5万 USD |
| 研究与开发 | 651.52万 USD |
| 销售、一般及管理费用 | 6582.77万 USD |
| 营业费用 | 7234.29万 USD |
| 利息支出 | 96.74万 USD |
| 折旧和摊销 | 15.17万 USD |
| 营业利润 | −4636.79万 USD |
| 净利润 | −4649.82万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$25.00
上涨空间 190.70%报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI356.9万0.00%2.3万亿 USD0.03%US$381.57-0.10%
iShares Russell 2000 ETFIWM172.34万0.00%787.4亿 USD0.19%US$277.9-0.37%
Vanguard Extended Market ETFVXF129.28万0.00%954亿 USD0.05%US$233.52-0.63%
iShares Russell 2000 Growth ETFIWO45.56万0.00%139.17亿 USD0.24%US$353.71-0.86%
Schwab U.S. Small-Cap ETFSCHA45.27万0.00%218.24亿 USD0.03%US$32.66-0.40%
iShares Micro-Cap ETFIWC26.14万0.02%13.17亿 USD0.60%US$181.66-0.73%
Vanguard Russell 2000 ETFVTWO13.26万0.00%180亿 USD0.06%US$112.27-0.35%
Global X - Russell 2000 ETFRSSL4万—14.19亿 USD0.08%US$108.72-0.34%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOSchwab U.S. Small-Cap ETFSCHAiShares Micro-Cap ETFIWCVanguard Russell 2000 ETFVTWOGlobal X - Russell 2000 ETFRSSLAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
